Opens in a new tab

Amycel v Szymon Spyra (CFI, 21 June 2024)

Date21 June 2024
CourtCFI
DivisionThe Hague (NL) Local Division
Type of actionGeneric application
Case number(s)UPC_CFI_195/2024
Registry referenceApp_35134/2024 · ORD_35405/2024 · UPC_CFI_195/2024
PartiesSpyra Szymon Spyra

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 25 June 2024 (UPC_CFI_195/2024, ACT_23163/2024, App_35134/2024, ORD_35405/2024), the judge-rapporteur of The Hague Local Division (M. Kokke), in provisional measures proceedings brought by Amycel LLC, proprietor of EP 1 993 350, against Szymon Spyra, rejected the request for court-arranged simultaneous English-Polish interpretation at the hearing on 9 July 2024, but allowed the defendant to engage an interpreter at his own expense. The order sets out the two-step assessment under Rule 109 RoP.

Question

Can an individual defendant domiciled in Poland obtain simultaneous interpretation at the hearing as part of the costs of the proceedings under Art. 51(2) UPCA and Rule 109.1 RoP?

Decision

Rule 109 RoP calls for a double appropriateness test: is interpretation appropriate, and should its costs become costs of the proceedings (paragraph 5)? The threshold is low under Rule 109.1 and lower still under Rule 109.4, the judge-rapporteur respects the defendant’s own assessment of his English and allows interpretation in principle (paragraphs 7 and 8). However, Polish is not an official or designated language of the division or of the EPO, and the court cannot provide translations into every language. The defendant expanded his business into UPC territory, where English is the general business language (paragraphs 10 and 11). Court-arranged interpretation is therefore refused at this stage (paragraph 12). The defendant may later seek recovery of interpretation costs as costs of the proceedings if bearing them proves unreasonable, which at least requires Amycel’s action to be dismissed with a costs order against it (paragraph 13).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts. 51(1), 51(2) and 53(1)(a)
Rules of Procedure
Rules 109.1, 109.2, 109.4, 109.5 and 150

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_195/2024 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
La demande d'interprétation simultanée organisée par la juridiction est rejetée. Le défendeur peut recourir à un interprète à ses frais, sous réserve d'un remboursement ultérieur au titre des frais de procédure.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 1 993 350
Brown mushrooms for commercial production
recorded proprietor: Amycel LLC
Mentioned in the analysis (role not qualified)
Also mentioned in 11 other decision(s): Name not displayed for GDPR reasons. Represented by Michal PRZYLUSKI v · *** v AMYCEL (CoA, 2 July 2026) · Applicant *** v Amycel (CoA, 24 March 2026) · Applicant *** v Amycel (CoA, 16 January 2026) · Amycell v *** (CFI, 9 December 2025) · Amycel v XXX (CFI, 21 October 2025) · Amycel v *** (CFI, 1 April 2025) · Amycel v *** (CFI, 18 December 2024)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.